Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 181

1.

Prostate-specific antigen-based risk-adapted discontinuation of prostate cancer screening in elderly African American and Caucasian American men.

Tang P, Sun L, Uhlman MA, Robertson CN, Polascik TJ, Albala DM, Donatucci CF, Moul JW.

Urology. 2010 Nov;76(5):1058-62. doi: 10.1016/j.urology.2009.09.049. Epub 2009 Dec 29.

PMID:
20035982
2.

African-American race is a predictor of prostate cancer detection: incorporation into a pre-biopsy nomogram.

Yanke BV, Carver BS, Bianco FJ Jr, Simoneaux WJ, Venable DD, Powell IJ, Eastham JA.

BJU Int. 2006 Oct;98(4):783-7.

4.
5.
6.

The association between presentation PSA and race in two sequential time periods in prostate cancer patients seen at a university hospital and its community affiliates.

Pan CC, Lee JS, Chan JL, Sandler HM, Underwood W, McLaughlin PW.

Int J Radiat Oncol Biol Phys. 2003 Dec 1;57(5):1292-6.

PMID:
14630264
7.

The impact of race on prostate cancer detection and choice of treatment in men undergoing a contemporary extended biopsy approach.

Swords K, Wallen EM, Pruthi RS.

Urol Oncol. 2010 May-Jun;28(3):280-4. doi: 10.1016/j.urolonc.2008.09.021. Epub 2008 Dec 12.

PMID:
19070516
8.

Prostate specific antigen levels in young adulthood predict prostate cancer risk: results from a cohort of Black and White Americans.

Whittemore AS, Cirillo PM, Feldman D, Cohn BA.

J Urol. 2005 Sep;174(3):872-6; discussion 876.

PMID:
16093978
9.

Prostate-specific antigen as predictor of prostate cancer in black men and white men.

Whittemore AS, Lele C, Friedman GD, Stamey T, Vogelman JH, Orentreich N.

J Natl Cancer Inst. 1995 Mar 1;87(5):354-60.

PMID:
7531773
10.

Statewide analysis of serum prostate specific antigen levels in Louisiana men without prostate cancer.

Kyle C, Ewing T, Wu XC, Mercante D, Lifsey D, Meunier C, Jefferson L, Sartor O, Rayford W.

J La State Med Soc. 2004 Nov-Dec;156(6):319-23.

PMID:
15688673
11.

Clinical characteristics of prostate cancer in African Americans, American whites, and Senegalese men.

Gueye SM, Zeigler-Johnson CM, Friebel T, Spangler E, Jalloh M, MacBride S, Malkowicz SB, Rebbeck TR.

Urology. 2003 May;61(5):987-92.

PMID:
12736021
12.

Prostate-specific antigen test use and digital rectal examinations among African-American men, 2002-2006.

Ross LE, Meade SA, Powe BD, Howard DL.

J Natl Black Nurses Assoc. 2009 Jul;20(1):52-8.

PMID:
19691184
13.

Postprostatectomy cancer-free survival of African Americans is similar to non-African Americans after adjustment for baseline cancer severity.

Underwood W 3rd, Wei J, Rubin MA, Montie JE, Resh J, Sanda MG.

Urol Oncol. 2004 Jan-Feb;22(1):20-4.

PMID:
14969799
14.

Association of African-American ethnic background with survival in men with metastatic prostate cancer.

Thompson I, Tangen C, Tolcher A, Crawford E, Eisenberger M, Moinpour C.

J Natl Cancer Inst. 2001 Feb 7;93(3):219-25.

PMID:
11158191
15.

Age-specific distribution of serum prostate-specific antigen in a community-based study of African-American men.

Cooney KA, Strawderman MS, Wojno KJ, Doerr KM, Taylor A, Alcser KH, Heeringa SG, Taylor JM, Wei JT, Montie JE, Schottenfeld D.

Urology. 2001 Jan;57(1):91-6. Review.

PMID:
11164150
16.

Racial differences in screening for prostate cancer in the elderly.

Gilligan T, Wang PS, Levin R, Kantoff PW, Avorn J.

Arch Intern Med. 2004 Sep 27;164(17):1858-64.

PMID:
15451760
17.

Characteristics of baseline PSA and PSA velocity in young men without prostate cancer: Racial differences.

Tang P, Du W, Xie K, Fu J, Chen H, Yang W, Moul JW.

Prostate. 2012 Feb 1;72(2):173-80. doi: 10.1002/pros.21418. Epub 2011 May 2.

PMID:
21538426
18.

Benign prostatic hyperplasia: racial differences in treatment patterns and prostate cancer prevalence.

Pettaway CA, Lamerato LE, Eaddy MT, Edwards JK, Hogue SL, Crane MM.

BJU Int. 2011 Oct;108(8):1302-8. doi: 10.1111/j.1464-410X.2010.09991.x. Epub 2011 Mar 4.

19.
20.

Supplemental Content

Support Center